Defiance Daily Target 2X Long NVO ETF (NVOX)

Assets	$38.39M
Expense Ratio	1.30%
PE Ratio	n/a
Shares Out	2.59M
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	281,252
Open	15.07
Previous Close	14.83
Day's Range	14.73 - 15.17
52-Week Low	9.23
52-Week High	36.00
Beta	n/a
Holdings	12
Inception Date	Dec 2, 2024

About NVOX

Fund Home Page

The Defiance Daily Target 2X Long NVO ETF (NVOX) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to deliver 2x leveraged exposure to the daily share price movement of NOVO Nordisk A/S - ADR (NVO), less fees and expenses, through derivatives like swap agreements. NVOX was launched on Dec 2, 2024 and is issued by Defiance.

• Asset Class: Equity
• Category: Trading--Leveraged Equity
• Stock Exchange: NYSEARCA
• Ticker Symbol: NVOX
• ETF Provider: Defiance

Top 10 Holdings

273.65% of assets

Name	Symbol	Weight
NOVO-NORDISK SWAP MS	n/a	65.54%
US DOLLARS	n/a	30.05%
NOVO-NORDISK A/S-SPONS ADR NOMURA	n/a	24.57%
NOVO-NORDISK SWAP NBC-L	n/a	24.51%
OTHER ASSETS AND LIABILITIES	n/a	24.06%
NOVO-NORDISK SWAP BMO-L	n/a	22.96%
NOVO-NORDISK SWAP CLEARSTREET	n/a	22.64%
NOVO-NORDISK SWAP MAREX	n/a	22.32%
NOVO-NORDISK INC SWAP CANTOR	n/a	20.91%
First American Government Obligations Fund Class X	FGXXX	16.08%

Performance

NVOX had a total return of -51.53% in the past year, including dividends. Since the fund's inception, the average annual return has been -75.42%.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP. Several fund data points are also provided by Finnhub.

Last checked:

Aug 25, 2026

Data Sources Report a data error